Fox Chase Cancer Center
Research and Technology Symposium

Tuesday May 20
8:oo am – 6:00 pm
The Academy of Natural Sciences
1900 Benjamin Franklin Parkway
Philadelphia
Please use entrance on 19th St.

« About the Symposium

The Office of Business Development
at the Fox Chase Cancer Center
is pleased to announce the Agenda of its inaugural
Research and Technology Symposium,
featuring the title of presentations, posters, and technologies available for licensing.

We look forward to meeting you at the event

Agenda

8:00-8:45	Breakfast and Registration
8:45-8:50	Kurt Schwinghammer, PhD, Director of Business Development: Introduction to the Day
8:50-9:00	J Robert Beck, MD, Chief Academic Officer; Office of the President: Welcoming Remarks
9:00-9:20	Kerry Campbell, PhD: A Genetically-modified NK Cell Line Expressing the Fc Receptor, CD16, for Use in ADCC Assays
9:20-9:40	Erica Golemis, PhD: Informatics-guided Screening Approaches to Improving Cancer Therapy
9:40-10:00	Denise Connolly, PhD: Using Mouse Models to Study Ovarian Tumor Biology
10:00-10:20	Glenn Rall, PhD: Double Trouble: How Concomitant Immune Challenges can Result in Neurological Disease
10:20-10:40	Coffee Break
10:40-11:00	Annette Tobia, PhD, JD; Founder & CEO: Dynamis Therapeutics: A Fox Chase Start-up Focused on New Drugs to Treat Chronic Inflammatory Disease
11:00-11:20	Roland Dunbrack, PhD: Methods for Protein Structure Prediction
11:20-11:40	Gregory Adams, PhD: Engineered Antibody-based Molecules for the Treatment of Ovarian Cancer
11:40-12:00	Jonathan Chernoff, MD, PhD: P21-activated Kinases: New Targets in Cancer Therapeutics
12:00-12:20	Jeffrey Peterson, PhD: Chemical Genetic Approaches to Inhibitor Discovery
12:20-1:40	Lunch and Poster Presentation — For a List of Featured Posters and Technologies Click HERE
1:40-2:00	Elizabeth Henske, MD: Tuberous Sclerosis Research: Unlocking the Pathogenesis of Cancer, Autism, and More
2:00-2:20	David Wiest, PhD: Exploration of the Prognostic Value of Rpl22 Mutations in T-acute Lymphoblastic Leukemia
2:20-2:40	Margie Clapper, PhD: Strategies for the Early Detection and Prevention of Cancer in Mouse Models
2:40-3:00	Kenneth Zaret, PhD: From Science to Stem Cell Therapeutics: Opportunities for Licensing and Collaboration
3:00-3:15	Coffee Break
3:20-3:40	Alfonso Bellacosa, MD, PhD: Markers for Early Diagnosis and Prevention of Cancer
3:40-4:00	Luis J. Sigal, DVM, PhD: A Novel Concept for Antiviral Vaccines and Therapies
4:00-4:20	Nancy Lewis, MD: Fox Chase Phase I Clinical Trial Program: An Overview
4:30-6:00	Networking Reception A final networking reception will take place to meet with Business Development colleagues in other Companies, investigators and clinical scientists, in the beautiful setting of The Academy of Natural Sciences in downtown Philadelphia.

For more information, contact the Fox Chase Office of Business Development.